via Stable Diffusion
A new type of vaccine developed by researchers at the University of Chicago’s Pritzker School of Molecular Engineering (PME) has shown in the lab setting that it can completely reverse autoimmune diseases like multiple sclerosis and type 1 diabetes— all without shutting down the rest of the immune system.
A typical vaccine teaches the human immune system to recognize a virus or bacteria as an enemy that should be attacked. The new “inverse vaccine” does just the opposite: it removes the immune system’s memory of one molecule. While such immune memory erasure would be unwanted for infectious diseases, it can stop autoimmune reactions like those seen in multiple sclerosis, type I diabetes, or rheumatoid arthritis, in which the immune system attacks a person’s healthy tissues.
The inverse vaccine, described in Nature Biomedical Engineering, takes advantage of how the liver naturally marks molecules from broken-down cells with “do not attack” flags to prevent autoimmune reactions to cells that die by natural processes. PME researchers coupled an antigen — a molecule being attacked by the immune system— with a molecule resembling a fragment of an aged cell that the liver would recognize as friend, rather than foe. The team showed how the vaccine could successfully stop the autoimmune reaction associated with a multiple-sclerosis-like disease.
“In the past, we showed that we could use this approach to prevent autoimmunity,” said Jeffrey Hubbell, the Eugene Bell Professor in Tissue Engineering and lead author of the new paper. “But what is so exciting about this work is that we have shown that we can treat diseases like multiple sclerosis after there is already ongoing inflammation, which is more useful in a real-world context.”
Unwinding an immune response
The job of the immune system’s T cells is to recognize unwanted cells and molecules — from viruses and bacteria to cancers — as foreign to the body and get rid of them. Once T cells launch an initial attack against an antigen, they retain a memory of the invader to eliminate it more quickly in the future.
T cells can make mistakes, however, and recognize healthy cells as foreign. In people with multiple sclerosis, for instance, T cells mount an attack against myelin, the protective coating around nerves.
Hubbell and his colleagues knew that the body has a mechanism for ensuring that immune reactions don’t occur in response to every damaged cell in the body — a phenomenon known as peripheral immune tolerance, which is carried out in the liver. They discovered in recent years that tagging molecules with a sugar known as N-acetylgalactosamine (pGal) could mimic this process, sending the molecules to the liver where tolerance to them develops.
“The idea is that we can attach any molecule we want to pGal and it will teach the immune system to tolerate it,” explained Hubbell. “Rather than rev up immunity as with a vaccine, we can tamp it down in a very specific way with an inverse vaccine.”
“We have shown that we can treat diseases like multiple sclerosis after there is already ongoing inflammation.”
Prof. Jeffrey Hubbell
Prof. Jeffrey Hubbell
In the new study, the researchers focused on a multiple-sclerosis-like disease in which the immune system attacks myelin, leading to weakness and numbness, loss of vision and, eventually mobility problems and paralysis. The team linked myelin proteins to pGal and tested the effect of the new inverse vaccine. The immune system, they found, stopped attacking myelin, allowing nerves to function correctly again and reversing symptoms of disease in animals.
In a series of other experiments, the scientists showed that the same approach worked to minimize other ongoing immune reactions.
Toward clinical trials
Today, autoimmune diseases are generally treated with drugs that broadly shut down the immune system.
“These treatments can be very effective, but you’re also blocking the immune responses necessary to fight off infections and so there are a lot of side effects,” said Hubbell. “If we could treat patients with an inverse vaccine instead, it could be much more specific and lead to fewer side effects.”
“Rather than rev up immunity as with a vaccine, we can tamp it down in a very specific way with an inverse vaccine.”
Prof. Jeffrey Hubbell
Prof. Jeffrey Hubbell
Initial phase I safety trials of a glycosylation-modified antigen therapy based on this preclinical work have already been carried out in people with celiac disease, an autoimmune disease that is associated with eating wheat, barley and rye, and phase I safety trials are under way in multiple sclerosis. Those trials are conducted by the pharmaceutical company Anokion SA, which helped fund the new work and which Hubbell cofounded and is a consultant, board member, and equity holder. The Alper Family Foundation also helped fund the research.
“There are no clinically approved inverse vaccines yet, but we’re incredibly excited about moving this technology forward,” says Hubbell.
Original Article: “Inverse vaccine” shows potential to treat multiple sclerosis and other autoimmune diseases
More from: University of Chicago | Pritzker School of Molecular Engineering at the University of Chicago
The Latest Updates from Bing News
Go deeper with Bing News on:
Inverse vaccine
- Nykode Therapeutics Pursuing Fast-to-Market Strategy for HPV16-Targeted Cancer Vaccine
The firm's long-term goal is to develop targeted cancer vaccines for patients at every stage of disease, including pre-cancer.
- Man receives world’s first melanoma vaccine — trial underway
A trial for the world’s first-ever mRNA cancer vaccine for melanoma is underway in the UK. Melanoma is the deadliest form of skin cancer. Around 100,000 Americans are expected to be diagnosed ...
- COVID-19 Vaccine Tracker
A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna ...
- 14 recent scientific breakthroughs
Editor's note: This article was updated April 18, 2024. Scientists in many fields received little recognition for the last couple of years, as the world focused on the emergency push to develop ...
- Why Don’t We Have A Cure For Cavities? Inside the Decades-Long Scientific Quest
Scientists have been trying to manipulate the way our oral microbes interact with our teeth to prevent cavities for decades — they might be closer than ever.
Go deeper with Bing News on:
Reversing autoimmune diseases
- Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Topline data from Phase 2b trial of Descartes-08,the Company’s potential first-in-class mRNA CAR-T cell therapy, in myasthenia gravis on track ...
- Researchers make strides in understanding little-known autoimmune myelin-impairing disorder
Blindness and paralysis are often the devastating consequences of little-known disease myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). An Australian research collaboration is ...
- Arthritis News
Study Finds New Treatment to Reverse Inflammation and Arterial ... arthritis might prevent the development of autoimmune thyroid disease, according to a new observational ...
- Best Paleo Diet Meal Delivery Plans of 2024
Such was the case for Sarah Ballantyne, who has a doctorate in medical biophysics and is the author of The Paleo Approach: Reverse Autoimmune Disease and Heal Your Body. She found that following ...
- Another Monoclonal Antibody Delays Diabetes in Mouse Study
Johns Hopkins researchers have shown that a monoclonal antibody can reverse type 1 diabetes. It targets a different antigen than Tzield.